CD8A and melanoma: The CD8+ T cells in patients expressed lower levels of HLA-DR (Figure 2b), an activation marker on T cells.17 The expression of PD-1, which is an inhibitory ligand for T cell stimulation that also may be upregulated during T cell activation, was higher on both CD4+ and CD8+ T cells from melanoma patients (Figure 2c).